Bullet Biotechnology Overview

  • Founded
  • 2011
Founded
  • Status
  • Out of Business
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Out of Business

Bullet Biotechnology General Information

Description

Developer of highly targeted immunotherapies intended to help patients fight disease effectively. The company's highly targeted immunotherapies is developing a therapy to fight cancer, by training the body to trigger an immune response towards a particular identifier on an individual patient's cancer cells, thereby eliminating these cells as threats, enabling patients to stimulate a person's own immune system to overcome disease.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 2686 Middlefield
  • Suite D
  • Redwood City, CA 94063
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bullet Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jan-2018 00.000 Completed Out of Business
4. Convertible Debt 28-Jun-2016 00000 00.000 Completed Product Development
3. Early Stage VC 23-Mar-2015 00000 00.000 Completed Startup
2. Angel (individual) 12-Sep-2013 $1.14M $2.49M 00.00 Completed Startup
1. Angel (individual) 08-Feb-2012 $1.36M $1.36M 00.000 Completed Startup
To view Bullet Biotechnology’s complete valuation and funding history, request access »

Bullet Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00 00 00 00 00.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
To view Bullet Biotechnology’s complete cap table history, request access »

Bullet Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of highly targeted immunotherapies intended to help patients fight disease effectively. The company's highly t
Biotechnology
Redwood City, CA
5 As of 2016
00.000
00000000 00 00.000

00000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00

00 00000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
0000 000000000
Copenhagen, Denmark
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bullet Biotechnology Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Sciences Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
00 0000000 Venture Capital-Backed Copenhagen, Denmark 00 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 25 competitors. Get the full list »

Bullet Biotechnology Executive Team (4)

Name Title Board Seat Contact Info
Mark Robbins Ph.D Chief Operating Officer
Thomas Theriault Ph.D Co-Founder & Chief Scientific Officer
Diego Fonstad Co-Founder & Director
You’re viewing 3 of 4 executive team members. Get the full list »

Bullet Biotechnology Board Members (5)

Name Representing Role Since
Diego Fonstad Bullet Biotechnology Co-Founder & Director 000 0000
Hari Kumar Ph.D Self Board Member 000 0000
James Swartz Self Board Member, Advisor & Co-Founder 000 0000
Jay Shepard Self Director 000 0000
Samuel Saks MD Self Director 000 0000
To view Bullet Biotechnology’s complete board members history, request access »

Bullet Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial